• The Porcine Vaccines market was valued at USD 1.29 billion in 2024 and is expected to grow to USD 1.83 billion by 2032, exhibiting a CAGR of 4.6% from 2025 to 2032. This consistent growth trajectory reflects rising demand for swine-derived products, increasing outbreaks of swine diseases, and heightened awareness of animal health and welfare.
Email: help@intelmarketresearch.com +91 9169164321
• The need for efficient vaccines has increased dramatically due to the growing prevalence of infectious swine diseases like Porcine Reproductive and Respiratory Syndrome (PRRS), African Swine Fever (ASF), and Classical Swine Fever (CSF). By decreasing productivity, raising mortality rates (which can reach 90% in afflicted herds), and causing trade restrictions that affect the world's pork markets, these diseases result in significant financial losses. To protect herd health and maintain stable pork supply chains, governments and the private sector are stepping up vaccination campaigns. An estimated 200 million pigs, or nearly 40% of the nation's pig population at the time, were culled as a result of the 2018 African Swine Fever outbreak in China.
Email:
• DNA Vaccines
•Inactivated (Killed) Vaccines
•Live Attenuated Vaccines
•Other
• Veterinary Hospitals & Clinic • Pharmacies & Veterinary Drug Stores • Online Sales (E-commerce Platforms) • Direct Sales to Farms & Integrators
Email: help@intelmarketresearch.com
